US2832685A
(en)
|
1952-05-24 |
1958-04-29 |
Crest Foods Co Inc |
Solubilization of milk proteins
|
GB894095A
(en)
|
1960-02-08 |
1962-04-18 |
Tanaka Shoichi |
A therapeutic device for personal wear
|
US3528960A
(en)
|
1968-10-07 |
1970-09-15 |
Lilly Co Eli |
N-carboxyaroyl insulins
|
US3719655A
(en)
|
1969-12-05 |
1973-03-06 |
Lilly Co Eli |
Process for the crystallization of the ammonium and alkali metal salts in insulin
|
US3950517A
(en)
|
1970-05-08 |
1976-04-13 |
National Research Development Corporation |
Insulin derivatives
|
US3869437A
(en)
|
1970-05-08 |
1975-03-04 |
Nat Res Dev |
Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
US4033941A
(en)
|
1975-12-17 |
1977-07-05 |
Eli Lilly And Company |
Process for purifying glucagon
|
GB1492997A
(en)
|
1976-07-21 |
1977-11-23 |
Nat Res Dev |
Insulin derivatives
|
JPS6030650B2
(ja)
|
1979-10-26 |
1985-07-17 |
日本油脂株式会社 |
座薬基剤組成物
|
JPS5767548A
(en)
|
1980-10-14 |
1982-04-24 |
Shionogi & Co Ltd |
Insulin analog and its preparation
|
NL193099C
(nl)
|
1981-10-30 |
1998-11-03 |
Novo Industri As |
Gestabiliseerde insuline-oplossing.
|
US4839341A
(en)
|
1984-05-29 |
1989-06-13 |
Eli Lilly And Company |
Stabilized insulin formulations
|
DK347086D0
(da)
|
1986-07-21 |
1986-07-21 |
Novo Industri As |
Novel peptides
|
PH25772A
(en)
|
1985-08-30 |
1991-10-18 |
Novo Industri As |
Insulin analogues, process for their preparation
|
US4849227A
(en)
|
1986-03-21 |
1989-07-18 |
Eurasiam Laboratories, Inc. |
Pharmaceutical compositions
|
PH23446A
(en)
|
1986-10-20 |
1989-08-07 |
Novo Industri As |
Peptide preparations
|
US5266310A
(en)
|
1987-09-17 |
1993-11-30 |
Boehringer Ingelheim International Gmbh |
Stabilization of therapeutically active proteins in pharmaceutical preparations
|
JPH01254699A
(ja)
|
1988-04-05 |
1989-10-11 |
Kodama Kk |
インスリン誘導体及びその用途
|
DK257988D0
(da)
|
1988-05-11 |
1988-05-11 |
Novo Industri As |
Nye peptider
|
EP0425482B1
(en)
|
1988-07-20 |
1993-08-18 |
Novo Nordisk A/S |
Human insulin analogs and preparations containing them
|
GB2222770B
(en)
|
1988-09-16 |
1992-07-29 |
Sandoz Ltd |
Pharmaceutical compositions containing cyclosporins
|
US5225323A
(en)
|
1988-11-21 |
1993-07-06 |
Baylor College Of Medicine |
Human high-affinity neurotransmitter uptake system
|
WO1990007522A1
(en)
|
1988-12-23 |
1990-07-12 |
Novo Nordisk A/S |
Human insulin analogues
|
US5716927A
(en)
|
1988-12-23 |
1998-02-10 |
Novo Nordisk A/S |
Insulin analogs having a modified B-chain
|
DE3844211A1
(de)
|
1988-12-29 |
1990-07-05 |
Hoechst Ag |
Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
|
US5514646A
(en)
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
HU210142B
(en)
|
1989-04-20 |
1995-02-28 |
Sinai School Medicine |
Process for producing hepatospecific insulin-analogues and pharmaceutical compositions containing them
|
CA1340994C
(en)
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
AU6417790A
(en)
|
1989-09-22 |
1991-04-18 |
Tsi-Madison Research Institute |
Method and compositions for one-step cryopreservation of embryos
|
CA2027930C
(en)
|
1989-10-19 |
1998-06-30 |
Tsuyoshi Miyazaki |
Polymer complexes of a sugar response type
|
US5179189A
(en)
|
1990-01-19 |
1993-01-12 |
Nova Pharmaceutical Corporation |
Fatty acid terminated polyanhydrides
|
DK45590D0
(hu)
|
1990-02-21 |
1990-02-21 |
Novo Nordisk As |
|
DK155690D0
(da)
|
1990-06-28 |
1990-06-28 |
Novo Nordisk As |
Nye peptider
|
DK158390D0
(da)
|
1990-07-02 |
1990-07-02 |
Novo Nordisk As |
Nye peptider
|
AU8091091A
(en)
|
1990-07-26 |
1992-02-18 |
University Of Iowa Research Foundation, The |
Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule
|
JPH06501003A
(ja)
|
1990-09-13 |
1994-01-27 |
スミスクライン・ビーチャム・コーポレイション |
非水性液状経口懸濁液
|
DK10191D0
(da)
|
1991-01-22 |
1991-01-22 |
Novo Nordisk As |
Hidtil ukendte peptider
|
US5336782A
(en)
|
1991-04-24 |
1994-08-09 |
Kuraray Co., Ltd. |
Long chain carboxylic acid imide ester
|
EP0952855B1
(en)
|
1991-07-03 |
2005-07-27 |
Meditech Research Limited |
Use of hyaluronan in gene therapy
|
JPH06509796A
(ja)
|
1991-07-26 |
1994-11-02 |
スミスクライン・ビーチャム・コーポレイション |
W/oミクロエマルジョン
|
US5268453A
(en)
|
1991-08-08 |
1993-12-07 |
Scios Inc. |
Tissue-selective insulin analogs
|
US5206219A
(en)
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
CZ342492A3
(en)
|
1991-11-26 |
1993-06-16 |
Lilly Co Eli |
Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised
|
ES2099193T3
(es)
|
1991-12-18 |
1997-05-16 |
Hoechst Ag |
Procedimiento para la obtencion de soluciones con contenido en insulina.
|
WO1994008599A1
(en)
|
1992-10-14 |
1994-04-28 |
The Regents Of The University Of Colorado |
Ion-pairing of drugs for improved efficacy and delivery
|
EP0666752A4
(en)
|
1992-10-16 |
1996-09-11 |
Smithkline Beecham Corp |
THERAPEUTIC MICROEMULSIONS.
|
JPH08502490A
(ja)
|
1992-10-16 |
1996-03-19 |
スミスクライン・ビーチャム・コーポレイション |
組成物
|
WO1994019001A1
(en)
|
1993-02-17 |
1994-09-01 |
Smithkline Beecham Corporation |
Microemulsions comprising therapeutic peptides
|
EP0684834A4
(en)
|
1993-02-17 |
1996-09-25 |
Smithkline Beecham Corp |
MICROEMULSIONS CONTAINING THERAPEUTIC PEPTIDES.
|
DE69426292T2
(de)
|
1993-02-23 |
2001-05-17 |
Genentech, Inc. |
Stabilisierung von mit organischen lösungsmittel behandelten polypeptiden mit einem hilfsstoff
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
US5506203C1
(en)
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
KR100310122B1
(ko)
|
1993-09-17 |
2002-04-24 |
한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 |
아실화된인슐린
|
US6869930B1
(en)
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
GB9323588D0
(en)
|
1993-11-16 |
1994-01-05 |
Cortecs Ltd |
Hydrophobic preparation
|
PL179443B1
(pl)
|
1994-03-07 |
2000-09-29 |
Inhale Therapeutic Syst |
Kompozycja insuliny, sposób wytwarzania kompozycji insuliny i sposób wytwarzania dawki insuliny w postaci aerozolu PL PL PL PL
|
US6500645B1
(en)
|
1994-06-17 |
2002-12-31 |
Novo Nordisk A/S |
N-terminally extended proteins expressed in yeast
|
US5646242A
(en)
|
1994-11-17 |
1997-07-08 |
Eli Lilly And Company |
Selective acylation of epsilon-amino groups
|
US5693609A
(en)
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
GB2296712B
(en)
|
1995-01-05 |
1999-02-24 |
British Gas Plc |
Absorbents for separating nitrogen from a feed gas
|
CZ289343B6
(cs)
|
1995-03-17 |
2002-01-16 |
Novo Nordisk A/S |
Inzulinový derivát a farmaceutický prostředek pro léčení diabetes
|
US6251856B1
(en)
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
US5824638A
(en)
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
US20010041786A1
(en)
|
1995-06-07 |
2001-11-15 |
Mark L. Brader |
Stabilized acylated insulin formulations
|
DE69630527T2
(de)
|
1995-06-30 |
2004-08-05 |
Novo Nordisk A/S |
Vorbeugung einer krankheit mit diabetes charakter
|
US20030104981A1
(en)
|
1995-11-03 |
2003-06-05 |
Jelena Mandic |
Human insulin analogues
|
US6451970B1
(en)
|
1996-02-21 |
2002-09-17 |
Novo Nordisk A/S |
Peptide derivatives
|
WO1998001473A1
(en)
|
1996-07-05 |
1998-01-15 |
Novo Nordisk A/S |
Method for the production of precursors of insulin, precursors of insulin analogues, and insulin like peptides
|
EP0938502B1
(en)
|
1996-07-11 |
2004-10-06 |
Novo Nordisk A/S |
Selective acylation method
|
US5981489A
(en)
|
1996-07-18 |
1999-11-09 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
DK0821006T3
(da)
|
1996-07-26 |
2004-08-16 |
Aventis Pharma Gmbh |
Insulinderivater med öget zinkbinding
|
IL119029A0
(en)
|
1996-08-07 |
1996-11-14 |
Yeda Res & Dev |
Long-acting drugs and pharamaceutical compositions comprising them
|
US6160541A
(en)
|
1997-01-21 |
2000-12-12 |
Lear Automotive Dearborn Inc. |
Power consumption control for a visual screen display by utilizing a total number of pixels to be energized in the image to determine an order of pixel energization in a manner that conserves power
|
SK285019B6
(sk)
|
1997-01-30 |
2006-04-06 |
Novartis Ag |
Tvrdá želatínová tobolka
|
US5898067A
(en)
|
1997-02-07 |
1999-04-27 |
Novo Nordisk A/S |
Crystallization of proteins
|
US6310038B1
(en)
|
1997-03-20 |
2001-10-30 |
Novo Nordisk A/S |
Pulmonary insulin crystals
|
PE79099A1
(es)
|
1997-06-13 |
1999-08-24 |
Lilly Co Eli |
Formulaciones de insulina estables
|
US20020155994A1
(en)
*
|
1997-10-24 |
2002-10-24 |
Svend Havelund |
Aggregates of human insulin derivatives
|
EP1025125B1
(en)
|
1997-10-24 |
2003-06-25 |
Novo Nordisk A/S |
Aggregates of human insulin derivatives
|
PE123799A1
(es)
|
1997-10-24 |
1999-12-13 |
Lilly Co Eli |
Composiciones insolubles de insulina
|
ZA989744B
(en)
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
WO1999024071A1
(en)
|
1997-11-12 |
1999-05-20 |
Alza Corporation |
Method for decreasing self-association of polypeptides
|
US6531448B1
(en)
|
1997-12-23 |
2003-03-11 |
Eli Lilly And Company |
Insoluble compositions for controlling blood glucose
|
JP2002518408A
(ja)
|
1998-06-12 |
2002-06-25 |
キングス・カレツジ・ロンドン |
インスリン類似体
|
GB9814172D0
(en)
|
1998-06-30 |
1998-08-26 |
Andaris Ltd |
Formulation for inhalation
|
DK1107743T3
(da)
|
1998-08-25 |
2007-10-22 |
Advanced Inhalation Res Inc |
Stabile, spraytörrede proteinformuleringer
|
TW570805B
(en)
|
1998-09-01 |
2004-01-11 |
Hoffmann La Roche |
Water-soluble pharmaceutical composition in an ionic complex
|
US7030083B2
(en)
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
ATE277630T1
(de)
|
1998-10-16 |
2004-10-15 |
Novo Nordisk As |
Stabile konzentrierte insulin präparationen zur pulmonaren verabreichung
|
US6660715B2
(en)
|
1998-11-19 |
2003-12-09 |
Massachusetts Institute Of Technology |
Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
|
US7425541B2
(en)
|
1998-12-11 |
2008-09-16 |
Medarex, Inc. |
Enzyme-cleavable prodrug compounds
|
ES2180511T3
(es)
*
|
1999-01-26 |
2003-02-16 |
Lilly Co Eli |
Formulaciones monodispersas de analogos de insulina acilados hexamericos.
|
AU2879100A
(en)
|
1999-02-12 |
2000-08-29 |
Miles A. Libbey Iii |
Formulation and system for intra-oral delivery of pharmaceutical agents
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
WO2000061178A1
(en)
|
1999-04-13 |
2000-10-19 |
Inhale Therapeutics Systems, Inc. |
Pulmonary administration of dry powder formulations for treating infertility
|
CA2370302A1
(en)
|
1999-04-27 |
2000-11-02 |
Benjamin Lee Hughes |
Insulin crystals for pulmonary administration
|
US6746853B1
(en)
|
1999-05-19 |
2004-06-08 |
Xencor, Inc. |
Proteins with insulin-like activity useful in the treatment of diabetes
|
AU5144400A
(en)
|
1999-05-19 |
2000-12-05 |
Xencor, Inc. |
Novel proteins with insulin-like activity useful in the treatment of diabetes
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
AU5453300A
(en)
|
1999-06-29 |
2001-01-31 |
Eli Lilly And Company |
Insulin crystals for pulmonary administration
|
EA004631B1
(ru)
|
1999-12-16 |
2004-06-24 |
Эли Лилли Энд Компани |
Полипептидные композиции, обладающие повышенной стабильностью
|
WO2001052937A1
(en)
|
2000-01-24 |
2001-07-26 |
Medtronic Minimed, Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
WO2001072323A2
(en)
|
2000-03-24 |
2001-10-04 |
Genentech, Inc. |
Use of insulin for the treatment of cartilagenous disorders
|
AU2001263775A1
(en)
|
2000-06-02 |
2001-12-11 |
Novo-Nordisk A/S |
Glucose dependent release of insulin from glucose sensing insulin derivatives
|
CN1141974C
(zh)
|
2000-06-07 |
2004-03-17 |
张昊 |
结肠定位释放的口服生物制剂
|
KR100508695B1
(ko)
|
2001-02-13 |
2005-08-17 |
한국과학기술연구원 |
인슐린의 경구투여용 제형과 그의 제조방법
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
WO2002067969A2
(en)
|
2001-02-21 |
2002-09-06 |
Medtronic Minimed, Inc. |
Stabilized insulin formulations
|
CN1160122C
(zh)
|
2001-04-20 |
2004-08-04 |
清华大学 |
一种制备口服胰岛素油相制剂的方法
|
MXPA03010649A
(es)
|
2001-05-21 |
2005-10-05 |
Nektar Therapeutics |
Administracion pulmonar de insulina modificada quimicamente.
|
US6858580B2
(en)
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7186797B2
(en)
|
2001-08-10 |
2007-03-06 |
Epix Pharmaceuticals, Inc. |
Polypeptide conjugates with extended circulating half-lives
|
US7030082B2
(en)
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
ATE446971T1
(de)
|
2001-09-07 |
2009-11-15 |
Biocon Ltd |
Verfahren zur synthese von insulinpolypeptid- oligomer-konjugaten und proinsulinpolypeptid- oligomer-konjugaten und verfahren zu deren synthese
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US7312192B2
(en)
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
AU2002349295A1
(en)
|
2001-12-02 |
2003-06-17 |
Novo Nordisk A/S |
Glucose dependant release of insulin from glucose sensing insulin derivatives
|
US7317000B2
(en)
|
2001-12-02 |
2008-01-08 |
Novo Nordisk A/S |
Glucose-dependent insulins
|
ATE424815T1
(de)
|
2001-12-03 |
2009-03-15 |
Dor Biopharma Inc |
Stabilisierte umkehr-mizellen-zusammensetzungen und ihre verwendung
|
WO2003050276A1
(en)
|
2001-12-05 |
2003-06-19 |
Dow Global Technologies Inc. |
Method for immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications
|
AU2002346491A1
(en)
|
2001-12-19 |
2003-07-09 |
Eli Lilly And Company |
Crystalline compositions for controlling blood glucose
|
US20050014679A1
(en)
|
2001-12-20 |
2005-01-20 |
Beals John Michael |
Insulin molecule having protracted time action
|
UA46669C2
(uk)
|
2001-12-29 |
2005-12-15 |
Товариство З Обмеженою Відповідальністю "Мако" |
Спосіб приготування готової лікарської форми інсуліну пролонгованої дії
|
US8003605B2
(en)
|
2002-03-13 |
2011-08-23 |
Novo Nordisk A/S |
Minimising body weight gain in insulin treatment
|
JP2005526126A
(ja)
|
2002-05-07 |
2005-09-02 |
ノボ ノルディスク アクティーゼルスカブ |
インスリンアスパルト及びインスリンデテミアを含む可溶性製剤
|
JP5599543B2
(ja)
|
2002-05-07 |
2014-10-01 |
ノヴォ ノルディスク アー/エス |
単量体インスリン及びアシル化インスリンを含む可溶性製剤
|
US7601688B2
(en)
|
2002-06-13 |
2009-10-13 |
Biocon Limited |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
CN1165549C
(zh)
|
2002-06-15 |
2004-09-08 |
江苏万邦生化医药股份有限公司 |
胰岛素的纯化方法
|
AU2003272347A1
(en)
|
2002-09-17 |
2004-04-08 |
Merck And Co., Inc. |
Removal of aldehyde impurity by reactive polystyrene resin
|
US20050065066A1
(en)
*
|
2002-12-20 |
2005-03-24 |
Kaarsholm Niels Christian |
Stabilised insulin compositions
|
US20060258561A1
(en)
*
|
2003-03-13 |
2006-11-16 |
Novo Nordisk A/S |
Novel NPH insulin preparations
|
US20040185068A1
(en)
|
2003-03-18 |
2004-09-23 |
Zhi-Jian Yu |
Self-emulsifying compositions, methods of use and preparation
|
EP1633391B1
(en)
|
2003-06-03 |
2011-10-19 |
Novo Nordisk A/S |
Stabilized pharmaceutical peptide compositions
|
EP2292253A3
(en)
|
2003-06-03 |
2011-12-14 |
Novo Nordisk A/S |
Stabilized pharmaceutical peptide compositions
|
BRPI0411479A
(pt)
|
2003-06-17 |
2006-07-25 |
Sembiosys Genetics Inc |
métodos para a produção de insulina em plantas
|
US20050054818A1
(en)
|
2003-07-02 |
2005-03-10 |
Brader Mark Laurence |
Crystalline compositions for controlling blood glucose
|
EP1644411A2
(en)
|
2003-07-11 |
2006-04-12 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
WO2005012346A1
(en)
|
2003-07-25 |
2005-02-10 |
Conjuchem, Inc. |
Long lasting insulin derivatives and methods thereof
|
EP2264065B1
(en)
|
2003-08-05 |
2017-03-08 |
Novo Nordisk A/S |
Novel insulin derivatives
|
US20060198819A1
(en)
|
2003-08-08 |
2006-09-07 |
Novo Nordisk Healthcare A/G |
Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
|
US7635675B2
(en)
|
2003-08-13 |
2009-12-22 |
Biocon Limited |
Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
|
BRPI0414539B8
(pt)
|
2003-09-19 |
2021-05-25 |
Novo Nordisk As |
composto, composição farmacêutica, e, uso de um composto
|
EP1687428A1
(en)
|
2003-11-14 |
2006-08-09 |
Novo Nordisk A/S |
Processes for making acylated insulin
|
US20050118206A1
(en)
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
CN102784386A
(zh)
|
2003-11-20 |
2012-11-21 |
诺沃挪第克公司 |
对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂
|
US7371381B2
(en)
|
2003-12-12 |
2008-05-13 |
Amgen Inc. |
Anti-galanin antibodies and uses thereof
|
DE10358387A1
(de)
|
2003-12-13 |
2005-07-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung
|
JP4792457B2
(ja)
|
2004-03-26 |
2011-10-12 |
ユニヴァーシタ’デグリ ステュディ ディ パルマ |
高度に呼吸に適したインスリンのマイクロ粒子
|
KR20070044805A
(ko)
|
2004-04-15 |
2007-04-30 |
키아스마, 인코포레이티드 |
생물학적 장벽 투과를 촉진시킬 수 있는 조성물
|
CN101151048A
(zh)
|
2004-05-10 |
2008-03-26 |
纳斯泰克制药公司 |
增强甲状旁腺激素粘膜递送的组合物和方法
|
JP2008505866A
(ja)
|
2004-07-09 |
2008-02-28 |
ノボ ノルディスク アクティーゼルスカブ |
インスリンを含有する薬学的製剤
|
UA103758C2
(ru)
|
2004-07-19 |
2013-11-25 |
Биокон Лимитед |
Конъюгаты олигомеров инсулина, их композиции и применение
|
JP2008513356A
(ja)
|
2004-08-09 |
2008-05-01 |
アリオス バイオファーマ インク. |
合成高度糖鎖付加プロテアーゼ耐性ポリペプチド変異体、それを使用する経口製剤および方法
|
ES2540886T3
(es)
|
2004-08-23 |
2015-07-14 |
Mannkind Corporation |
Sales de dicetopiperazina para la administración de fármacos
|
WO2006035418A2
(en)
|
2004-09-27 |
2006-04-06 |
Sigmoid Biotechnologies Limited |
Microcapsules comprising a methylxanthine and a corticosteroid
|
CN101060856B
(zh)
*
|
2004-11-22 |
2011-01-19 |
诺和诺德公司 |
可溶、稳定的含胰岛素制剂
|
CA2587601C
(en)
|
2004-12-03 |
2017-11-07 |
Rhode Island Hospital |
Diagnosis and treatment of alzheimer's disease
|
WO2006079641A2
(en)
|
2005-01-27 |
2006-08-03 |
Novo Nordisk A/S |
Insulin derivatives conjugated with structurally well defined branched polymers
|
WO2006082205A1
(en)
|
2005-02-02 |
2006-08-10 |
Novo Nordisk A/S |
Insulin derivatives
|
ES2438145T3
(es)
|
2005-02-02 |
2014-01-16 |
Novo Nordisk A/S |
Nuevos derivados de insulina
|
WO2006082245A1
(en)
|
2005-02-07 |
2006-08-10 |
Novo Nordisk A/S |
Pharmaceutical preparations comprising insulin, zinc ions and a zinc-binding ligand
|
EP2242489A1
(en)
|
2005-02-15 |
2010-10-27 |
Jallal Messadek |
Combination therapeutic compositions and method of use
|
JP2008533100A
(ja)
|
2005-03-18 |
2008-08-21 |
ノボ ノルディスク アクティーゼルスカブ |
Peg化された単鎖インスリン
|
TWI362392B
(en)
|
2005-03-18 |
2012-04-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
WO2006103657A2
(en)
|
2005-03-31 |
2006-10-05 |
Dexcel Pharma Technologies Ltd. |
A solid composition for intra-oral delivery of insulin
|
EP1909824B1
(en)
|
2005-04-08 |
2011-05-18 |
Amylin Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising incretin peptide and aprotic polar solvent
|
CN101180081B
(zh)
|
2005-05-25 |
2015-08-26 |
诺沃-诺迪斯克有限公司 |
稳定的多肽制剂
|
WO2007006320A1
(en)
|
2005-07-12 |
2007-01-18 |
Sherine Hassan Abbas Helmy |
Drinkable oral insulin liquid and capsules
|
US20070086952A1
(en)
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
JP4710533B2
(ja)
|
2005-10-07 |
2011-06-29 |
株式会社豊田自動織機 |
牽引車両のドローバー装置
|
WO2007047948A2
(en)
|
2005-10-20 |
2007-04-26 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of rapid acting insulin
|
PT1969004E
(pt)
|
2005-12-28 |
2011-11-25 |
Novo Nordisk As |
Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
|
WO2007081824A2
(en)
|
2006-01-06 |
2007-07-19 |
Case Western Reserve University |
Fibrillation resistant proteins
|
JP2009527526A
(ja)
|
2006-02-21 |
2009-07-30 |
ノボ・ノルデイスク・エー/エス |
単鎖インスリンのアナログとその製薬的製剤
|
ATE557037T1
(de)
|
2006-02-27 |
2012-05-15 |
Novo Nordisk As |
Insulin derivate
|
JP2009530243A
(ja)
|
2006-03-13 |
2009-08-27 |
ノボ・ノルデイスク・エー/エス |
アシル化単鎖インスリン
|
EP1996223A1
(en)
|
2006-03-13 |
2008-12-03 |
Novo Nordisk A/S |
Acylated single chain insulin
|
ES2548393T3
(es)
|
2006-05-09 |
2015-10-16 |
Novo Nordisk A/S |
Derivado de insulina
|
ES2553154T3
(es)
|
2006-05-09 |
2015-12-04 |
Novo Nordisk A/S |
Derivado de la insulina
|
JP5550338B2
(ja)
|
2006-07-31 |
2014-07-16 |
ノボ・ノルデイスク・エー/エス |
ペグ化持続型インスリン
|
CN101541830A
(zh)
|
2006-09-22 |
2009-09-23 |
诺沃-诺迪斯克有限公司 |
蛋白酶抗性的胰岛素类似物
|
WO2008043033A2
(en)
|
2006-10-04 |
2008-04-10 |
Case Western Reserve University |
Fibrillation-resistant insulin and insulin analogues
|
ES2563038T3
(es)
|
2007-04-30 |
2016-03-10 |
Novo Nordisk A/S |
Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca
|
EP2152243A2
(en)
*
|
2007-04-30 |
2010-02-17 |
Novo Nordisk A/S |
Highly concentrated insulin solutions and compositions
|
JP2011504871A
(ja)
|
2007-06-01 |
2011-02-17 |
ノボ・ノルデイスク・エー/エス |
固体又は半固体担体中にペプチド薬剤を含む自然に分散可能なプレコンセントレイト
|
JP5675347B2
(ja)
|
2007-06-01 |
2015-02-25 |
ノボ・ノルデイスク・エー/エス |
安定した非水性薬学的組成物
|
ES2744384T3
(es)
|
2007-06-13 |
2020-02-24 |
Novo Nordisk As |
Formulación farmacéutica que comprende un derivado de insulina
|
EP2170945A1
(en)
|
2007-07-16 |
2010-04-07 |
Novo Nordisk A/S |
Protease stabilized, pegylated insulin analogues
|
EP2178909B1
(en)
|
2007-08-13 |
2015-10-21 |
Novo Nordisk A/S |
Rapid acting insulin analogues
|
WO2009022006A1
(en)
|
2007-08-15 |
2009-02-19 |
Novo Nordisk A/S |
Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
|
CN101784562B
(zh)
|
2007-08-15 |
2016-07-13 |
诺沃-诺迪斯克有限公司 |
具有酰基和亚烷基二醇部分的胰岛素类似物
|
US20090087484A1
(en)
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
PL2209800T3
(pl)
*
|
2007-11-16 |
2013-12-31 |
Novo Nordisk As |
Stabilne kompozycje farmaceutyczne zawierające liraglutyd i degludec
|
ES2618073T3
(es)
|
2008-03-14 |
2017-06-20 |
Novo Nordisk A/S |
Análogos de insulina estabilizados frente a proteasas
|
EP2910571B1
(en)
|
2008-03-18 |
2016-10-05 |
Novo Nordisk A/S |
Protease stabilized, acylated insulin analogues
|
US8993516B2
(en)
|
2008-04-14 |
2015-03-31 |
Case Western Reserve University |
Meal-time insulin analogues of enhanced stability
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
US9603904B2
(en)
|
2008-10-30 |
2017-03-28 |
Novo Nordisk A/S |
Treating diabetes melitus using insulin injections with less than daily injection frequency
|
US20110293714A1
(en)
|
2008-11-28 |
2011-12-01 |
Novo Nordisk A/S |
Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
|
CN102245633A
(zh)
|
2008-12-09 |
2011-11-16 |
诺沃—诺迪斯克有限公司 |
新的胰岛素类似物
|
WO2010092163A2
(en)
|
2009-02-13 |
2010-08-19 |
Boehringer Ingelheim International Gmbh |
Antidiabetic medications
|
JP2013504610A
(ja)
|
2009-09-16 |
2013-02-07 |
ノヴォ ノルディスク アー/エス |
インスリンを含む安定な非水性液体医薬組成物
|
EP2496213B1
(en)
|
2009-11-02 |
2015-08-12 |
Novo Nordisk A/S |
Pharmaceutical solution of non covalently bound albumin and acylated insulin
|
EP2523655A2
(en)
|
2010-01-12 |
2012-11-21 |
Novo Nordisk A/S |
Pharmaceutical compositions for oral administration of insulin peptides
|
BR112012033107A2
(pt)
*
|
2010-06-23 |
2016-10-11 |
Novo Nordisk As |
derivados de insulina contendo ligações dissulfeto adicionais.
|
JP5973427B2
(ja)
|
2010-06-23 |
2016-08-23 |
ノヴォ ノルディスク アー/エス |
追加のジスルフィド結合を含有するインスリン類似体
|
EP2627670A2
(en)
|
2010-10-15 |
2013-08-21 |
Novo Nordisk A/S |
Novel n-terminally modified insulin derivatives
|
US20130331320A1
(en)
*
|
2010-12-14 |
2013-12-12 |
Novo Nordisk A/S |
Fast-acting insulin in combination with long-acting insulin
|
WO2012171994A1
(en)
|
2011-06-15 |
2012-12-20 |
Novo Nordisk A/S |
Multi substituted insulins
|
CA2870313A1
(en)
|
2012-04-11 |
2013-10-17 |
Novo Nordisk A/S |
Insulin formulations
|
WO2014009316A1
(en)
|
2012-07-09 |
2014-01-16 |
Novo Nordisk A/S |
Novel use of insulin derivatives
|
EP2991672A1
(en)
|
2013-04-30 |
2016-03-09 |
Novo Nordisk A/S |
Novel administration regime
|
CN105324126A
(zh)
|
2013-06-21 |
2016-02-10 |
诺和诺德股份有限公司 |
Glp-1受体激动剂在用胰岛素治疗的和/或患有1型糖尿病的患者中的新用途
|
WO2015052088A1
(en)
*
|
2013-10-07 |
2015-04-16 |
Novo Nordisk A/S |
Novel derivative of an insulin analogue
|
CN104587455A
(zh)
*
|
2013-10-31 |
2015-05-06 |
江苏万邦生化医药股份有限公司 |
一种胰岛素制剂
|
FR3013049B1
(fr)
|
2013-11-14 |
2015-11-13 |
You-Ping Chan |
Analogue de l'insuline glargine
|
CN105899191B
(zh)
*
|
2014-01-09 |
2020-06-16 |
赛诺菲 |
胰岛素类似物和/或胰岛素衍生物的稳定化不含甘油的药物制剂
|
EP3113791B1
(en)
|
2014-03-07 |
2018-12-26 |
Jørgensen, Klavs Holger |
Novel fast acting insulin preparations
|
JO3624B1
(ar)
|
2014-05-08 |
2020-08-27 |
Lilly Co Eli |
تركيبات إنسولين سريعة المفعول
|
AR102869A1
(es)
|
2014-12-16 |
2017-03-29 |
Lilly Co Eli |
Composiciones de insulina de rápida acción
|
MX2019006463A
(es)
|
2016-12-16 |
2019-08-14 |
Novo Nordisk As |
Composiciones farmaceuticas que contienen insulina.
|